Occupational Therapists in Charleston, SC Accepting Medicare

173 Occupational Therapists found. Showing 121 - 140

Ruth A Hyde, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Mrs. Mary Ravenel Anderson, OTLR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1941 Savage Road, Ste 300a, Charleston, SC 29407 Phone: 843-402-1495    Fax: 843-402-1285

Kelly Brackman Schneider, OTR Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 169 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414

Meredith Adele Obaytek, OTR L Occupational Therapist - Hand Medicare: Not Enrolled in Medicare Practice Location: 1483 Tobias Gadson Blvd Ste 205b, Charleston, SC 29407 Phone: 843-766-6494    Fax: 843-766-6495

Mrs. Heather Weart Spann, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 559 White Chapel Cir, Charleston, SC 29412 Phone: 843-469-3929    Fax: 843-277-6443

Jessica Surface, MS, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1407 Ashley River Rd, Charleston, SC 29407 Phone: 843-769-0663    Fax: 843-769-0665

Northern Tides Speech And Language L.l.c. Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1744 Sam Rittenberg Blvd, Charleston, SC 29407 Phone: 607-423-6613    Fax: 843-375-6177

Linda Malear Occupational Therapist - Hand Medicare: Not Enrolled in Medicare Practice Location: 1941 Savage Rd, Ste 300a, Charleston, SC 29407 Phone: 843-402-1495    Fax: 843-402-1285

Ms. Brooke Danielle Critcher, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 930 Folly Rd, Suite B, Charleston, SC 29412 Phone: 888-510-6369    Fax: 888-510-9156

Mrs. Laura Allison Cramer, OTR L Occupational Therapist - Hand Medicare: Accepting Medicare Assignments Practice Location: 1483 Tobias Gadson Blvd, Suite 205b, Charleston, SC 29407 Phone: 843-766-6494    Fax: 843-766-6495

Ms. Kaitlyn Marie Huber, OT Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1644 Ashley Hall Rd, Charleston, SC 29407 Phone: 631-316-1494    Fax: 855-504-4089

Mrs. Megan Leigh Szatkowski, OTR-L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1407 Ashley River Rd, Charleston, SC 29407 Phone: 843-769-0663    Fax: 843-769-0665

Blair L Peeples, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1 Bishop Gadsden Way, Charleston, SC 29412 Phone: 843-406-6302    Fax: 843-406-6540

Lauren Flint, MOT Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1640 Ashley Hall Rd, Charleston, SC 29407 Phone: 774-721-6252

Mayra Carmen Fajardo Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 75 Calhoun St, Charleston, SC 29401 Phone: 973-632-3909

Dr. Victoria Kate Johnston, OTD Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2333 Ashley River Rd, Charleston, SC 29414 Phone: 843-258-5538

After Care Essentials Inc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1662 Savannah Hwy, Suite 230, Charleston, SC 29407 Phone: 843-571-5907    Fax: 843-571-5954

Sweetpea Therapy Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 420 Sumter St, Charleston, SC 29403 Phone: 609-276-1994

Katelyn Beuker, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1622 Wrecklers Race Ln, Charleston, SC 29414 Phone: 616-970-0709

Natalee Hutton Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2333 Ashley River Rd, Charleston, SC 29414 Phone: 843-258-5538

News Archive

Shire announces FDA approval of Vyvanse Capsules CII for ADHD in adolescents

Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents ages 13 to 17. The approval is based on study data demonstrating that Vyvanse improved ADHD symptoms compared to placebo in adolescents with ADHD. Vyvanse is also indicated for the treatment of ADHD in children ages 6 to 12 years, and adults.

Adding bortezomib ‘boosts acute myeloid leukemia chemotherapy response'

Older patients with untreated acute myeloid leukemia may benefit from having bortezomib added to daunorubicin and cytarabine during induction therapy and to consolidation intermediate-dose cytarabine, the results of a US study indicate.

HCRS awarded a contract to support AETC with medical records coding and training services

HealthCare Resolution Services, Inc., a leading provider of program integrity support, health information technology services and professional medical and technical staffing services, announced today that it has been awarded a contract with the U.S. Air Force's Commodities Council to support the Air Education and Training Command (AETC) with medical records coding and analysis, auditing, and provider training.

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.

Research reviews importance of blood-brain barrier, blood-tumor barrier in treatment of brain tumors

The research thoroughly reviews the importance of the blood-brain barrier (BBB) and the blood-tumor barrier (BTB) along with the current status and future perspectives of interesting physical and surgical strategies to circumvent these central nervous system (CNS) barriers in the treatment of malignant brain tumors.

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7(current)
• 8
• 9